Princeton, N.J., July 15, 2021: Certara, a global leader in biosimulation, today announced the appointments of Nancy Killefer and Cynthia Collins to its board of directors, effective August 1, 2021. The two additional appointments increase the company’s board of directors to eleven members. “It’s truly a pleasure to welcome Nancy and Cynthia to the board … Continued
PRINCETON, N.J.— July 14, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the second quarter of 2021 after the market close on Thursday, August 5, 2021. Company management will host a conference call to discuss financial results at 5:00 p.m. ET. Investors interested in … Continued
Veteran HR leader brings 20+ years of human resources experience to the company’s executive team PRINCETON, N.J.— July 13, 2021. Certara®, a global leader in biosimulation, today announced that it has appointed Nicolette D. Sherman to the position of Chief Human Resources Officer (CHRO). Sherman joins Certara with extensive experience in the biopharmaceutical industry, leading … Continued
Princeton, N.J., June 29, 2021: Certara, the global leader in biosimulation, today announced that it has been recognized as one of the “Best Places to Work” in New Jersey in 2021 by NJBIZ, one of New Jersey’s leading business journals. Certara is headquartered in Princeton, N.J. “We are honored to be named one of the … Continued
Do you love going to, or logging on, for work each day? Can’t stop bragging about all your company perks? Then there’s a chance that your employer is an NJBIZ Best Places to Work honoree. (…)
Dr. Gallagher brings more than 30 years of drug development and commercial leadership experience to her new role PRINCETON, N.J.—June 14, 2021. Certara, a global leader in biosimulation, today announced the addition of Carol Gallagher, Pharm.D., to its board of directors. Dr. Gallagher is an experienced biopharmaceutical director and operator and serves as a venture … Continued
PRINCETON, N.J.—May 20, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer, will participate in the following virtual investor conferences: Fireside Chat on Tuesday, June 1st at 11:40 a.m. ET Fireside Chat on Friday, June 4th at 10:00 a.m. ET … Continued
PRINCETON, N.J.—May. 6, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2021. Highlights: Revenue was $66.7 million, representing growth of 16% over the first quarter of 2020. Net income was $1.1 million, compared to a net income of $1.0 million in … Continued
PRINCETON, N.J.— April 30, 2021 — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will be participating in the BofA Securities 2021 Virtual Health Care Conference. William Feehery, CEO, and Andrew Schemick, CFO, are scheduled to present on Tuesday, May 11, 2021 at 2:45 p.m. ET. A live webcast will … Continued
PRINCETON, N.J.— April 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release preliminary financial results for the first quarter of 2021 after the market close on Thursday, May 6, 2021. Company management will host a conference call to discuss financial results at 5:00 p.m. ET. Investors interested … Continued
